MedPath

ZYDUS WORLDWIDE DMCC

🇦🇪United Arab Emirates
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

2 Phases

Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 3
1 (50.0%)

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

Phase 3
Completed
Conditions
Facial Rosacea
Interventions
First Posted Date
2019-09-27
Last Posted Date
2020-10-14
Lead Sponsor
Zydus Worldwide DMCC
Target Recruit Count
525
Registration Number
NCT04106726
Locations
🇺🇸

Zydus Worldwide DMCC, El Paso, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.